The clinical impact of humoral immunity in pediatric renal transplantation

Journal of the American Society of Nephrology

Volumn 24, Issue 4, 2013, Pages 655-664

  Chaudhuri, Abanti ^a   Ozawa, Mikki ^b   Everly, Matthew J ^b   Ettenger, Robert ^c   Dharnidharka, Vikas ^d   Benfield, Mark ^e   Mathias, Robert ^f   Portale, Anthony ^g   McDonald, Ruth ^h   Harmon, William ⁱ   Kershaw, David ^j   Vehaskari, V Matti ^k   Kamil, Elaine ^l   Baluarte, H Jorge ^m   Warady, Bradley ⁿ   Li, Li ^a   Sigdel, Tara K ^a,o   Hsieh, Szu Chuan ^a,o   Dai, Hong ^a,o   Naesens, Maarten ^p   Waskerwitz, Janie ^a   Salvatierra, Oscar ^a   Terasaki, Paul I ^q   Sarwal, Minnie M ^a,o   more..

^a STANFORD UNIVERSITY   (United States)

^b One Lambda Inc   (United States)

^c MATTEL CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f NEMOURS CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

^j UNIVERSITY OF MICHIGAN   (United States)

^k CHILDREN S HOSPITAL   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

^m CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁿ CHILDREN S MERCY HOSPITAL   (United States)

^o CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^p UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^q TERASAKI FOUNDATION LABORATORY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; HLA A ANTIGEN; HLA ANTIBODY; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ANTIBODY DETECTION; ARTICLE; CHILD UROLOGY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CREATININE CLEARANCE; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PRIORITY JOURNAL;

EID: 84875736279     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012070663     Document Type: Article

References (39)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383, 2004
2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342: 605-612, 2000
3. Zhang Q, Liang LW, Gjertson DW, Lassman C, Wilkinson AH, Kendrick E, Pham PT, Danovitch GM, Gritsch HA, Reed EF: Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation 79: 591-598, 2005
4. Terasaki PI, Ozawa M: Predicting kidney graft failure byHLA antibodies: A prospective trial. Am J Transplant 4: 438-443, 2004
5. Loupy A, Hill GS, Jordan SC: The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 8: 348-357, 2012
6. Sutherland SM, Li L, Sigdel TK, Wadia PP, Miklos DB, Butte AJ, Sarwal MM: Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int 76: 1277-1283, 2009
7. Morales-Buenrostro LE, Alberú J: Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation. Transplant Rev (Orlando) 22: 27-38, 2008
8. Sumitran-Holgersson S: Relevance of MICA and other non-HLA antibodies in clinical transplantation. Curr Opin Immunol 20: 607-613, 2008
9. Sigdel TK, Li L, Tran TQ, Khatri P, Naesens M, Sansanwal P, Dai H, Hsieh SC, Sarwal MM: Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. J Am Soc Nephrol 23: 750-763, 2012
10. Terasaki PI: Humoral theory of transplantation. Am J Transplant 3: 665-673, 2003
11. Terasaki PI, Cai J: Humoral theory of transplantation: Further evidence. Curr Opin Immunol 17: 541-545, 2005
12. Sarwal MM, Yorgin PD, Alexander S, Millan MT, Belson A, Belanger N, Granucci L, Major C, Costaglio C, Sanchez J, Orlandi P, Salvatierra O Jr: Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 72: 13-21, 2001
13. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr: Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 76: 1331-1339, 2003
14. Li L, Chang A, Naesens M, Kambham N, Waskerwitz J, Martin J, Wong C, Alexander S, Grimm P, Concepcion W, Salvatierra O, Sarwal MM: Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant 9: 1362-1372, 2009
15. Naesens M, Salvatierra O, Benfield M, Ettenger RB, Dharnidharka V, Harmon W, Mathias R, Sarwal MM; SNS01-NIH-CCTPT Multicenter Trial: Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation. Am J Transplant 12: 2730-2743, 2012
16. Sarwal MM, Ettenger RB, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, HarmonW, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Tang L, Liu J, Li L, Naesens M, Sigdel T, Waskerwitz J, Salvatierra O: Complete steroid avoidance is effective and safe in children with renal transplants: A multicenter randomized trial with three-year follow-up. Am J Transplant 12: 2719-2729, 2012
17. Lachmann N, Terasaki PI, Schönemann C: Donor-specific HLA antibodies in chronic renal allograft rejection: A prospective trial with a four-year follow-up. Clin Transpl 2006: 171-199, 2006
18. Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, Gautreau C, Charron D, Glotz D, Suberbielle-Boissel C: Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 21: 1398-1406, 2010
19. Li L, Khatri P, Sigdel TK, Tran T, Ying L, Vitalone MJ, Chen A, Hsieh S, Dai H, Zhang M, Naesens M, Zarkhin V, Sansanwal P, Chen R, Mindrinos M, Xiao W, Benfield M, Ettenger RB, Dharnidharka V, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Davis R, Butte AJ, Salvatierra O, Sarwal MM: A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant 12: 2710-2718, 2012
20. Colvin RB: Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 18: 1046-1056, 2007
21. Demirci C, Sen S, Sezak M, Sarsik B, Hosxcosxkun C, Töz H: Incidence and importance of c4d deposition in renal allograft dysfunction. Transplant Proc 40: 174-177, 2008
22. Haas M: C4d-negative antibody-mediated rejection in renal allografts: Evidence for its existence and effect on graft survival. Clin Nephrol 75: 271-278, 2011
23. Hachem RR, Yusen RD, Meyers BF, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP: Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant 29: 973-980, 2010
24. Everly MJ, Everly JJ, Arend LJ, Brailey P, Susskind B, Govil A, Rike A, Roy-Chaudhury P, Mogilishetty G, Alloway RR, Tevar A, Woodle ES: Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant 9: 1063-1071, 2009
25. Everly MJ: An update on antibody reduction and rejection reversal following bortezomib use: A report of 52 cases across 10 centers. Clin Transpl 2010: 353-362, 2010
26. Zou Y, Heinemann FM, Grosse-Wilde H, Sireci G, Wang Z, Lavingia B, Stastny P: Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates fromrejected kidney allografts byLuminex flowcytometry. HumImmunol 67: 230-237, 2006
27. Zou Y, Stastny P, Süsal C, Döhler B, Opelz G: Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 357: 1293-1300, 2007
28. Amézaga N, Crespo M, Lopez-Cobos M, Millán MA, Viñas O, Solé M, Oppenheimer F,Martorell J, Ercilla MG: Relevance ofMICA antibodies in acute humoral rejection in renal transplant patients. Transpl Immunol 17: 39-42, 2006
29. Mizutani K, Terasaki PI, Shih RN, Pei R, Ozawa M, Lee J: Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol 67: 223-229, 2006
30. Mizutani K, Shibata L, Ozawa M, Esquenazi V, Rosen A, Miller J, Terasaki PI: Detection of HLA and MICA antibodies before kidney graft failure. Clin Transpl 2006: 255-264, 2006
31. Terasaki PI, Cai J: Human leukocyte antigen antibodies and chronic rejection: From association to causation. Transplantation 86: 377-383, 2008
32. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A: Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10: 464-471, 2010
33. Sarwal M, Ettenger R, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Tang L, Liu J, Li L, Naesens M, Sigdel T, Waskerwitz J, Salvatierra O: Complete steroid avoidance is effective and safe in children with renal transplants: A multicenter randomized trial with three-year follow-up. Am J Transplant 12: 2719-2729, 2012
34. Naesens M, Lerut E, Damme BV, Vanrenterghem Y, Kuypers DR: Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. Am J Transplant 7: 2114-2123, 2007
35. Sutherland S, Li L, Concepcion W, Salvatierra O, Sarwal MM: Steroidfree immunosuppression in pediatric renal transplantation: Rationale for and [corrected] outcomes following conversion to steroid based therapy. Transplantation 87: 1744-1748, 2009
36. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou J, Ranshawa P, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal L, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
37. Isoniemi H, Taskinen E, Häyry P: Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 58: 1195-1198, 1994
38. Kambham N, Nagarajan S, Shah S, Li L, Salvatierra O, Sarwal MM: A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2: 135-142, 2007
39. Schwartz GJ, Gauthier B: A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106: 522-526, 1985